The agenda includes:
Development of positions on the evaluation of medicines:
- Ilaris (canacinumabum) under the drug programme: “Treatment of congenital autoinflammatory syndromes (ICD-10 E85, R50.9, D89.8, D89.9)”,
- Keytruda (pembrolizumabum) under the drug programme: “Treatment of patients with advanced colorectal cancer (ICD-10: C18 – C20).
Developing an opinion on a draft health policy programme of a local government unit: “Support for infertility treatment with the method of in vitro fertilization –for the inhabitants of the city of Tychy for 2022-2025”.